Success, safety, and efficacy of implantation of diamond-like carbon-coated stents

Angiology

Volumn 58, Issue 2, 2007, Pages 203-210

  Salahas, Anastasios ^a   Vrahatis, Antonios ^b   Karabinos, Ilias ^a,c   Antonellis, Ioannis ^a   Ifantis, Georgios ^a   Gavaliatsis, Isidoros ^a   Anthopoulos, Prodromos ^a   Tavernarakis, Antonios ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARBON; CLOPIDOGREL; DIAMOND; NITRATE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVASCULARIZATION; SAFETY; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARBON; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 34247573098     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707300360     Document Type: Article

References (38)

1. Hardhammar P., van Beusekom E., Emanuelson H.,, et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93: 423-430, 1996.
2. Bertrand OF, Sipehia R., Mongrain R.,, et al. Biocompatibility aspects of new stent technology. J Am Coll Cardiol 32: 562-571, 1998.
3. Ong AT, Aoki J., McFadden EP,, et al. Classification and current treatment options of in-stent restenosis. Present status and future perspectives. Herz 29: 187-194, 2004.
4. Lowe HC, Schwartz RS, MacNeill BD,, et al. The porcine coronary model of in-stent restenosis: Current status in the era of drug eluting stents. Catheter Cardiovasc Interv 60: 515-523, 2003.
5. Indolfi C., Mongiardo A., Curcio A.,, et al. Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents. Trends Cardiovasc Med 13: 142-148, 2003.
6. Spanos V., Stancovic G., Tobis J.,, et al. The challenge of in-stent restenosis: Insights from intravascular ultrasound. Eur Heart J 24: 138-150, 2003.
7. Holmes DR: In-stent restenosis. Rev Cardiovasc Med 2: 115-119, 2001.
8. Lu L., Jones MW: Diamond-like carbon as biological compatible material for cell culture and medical applications. Biomed Mater Eng 3: 223-228, 1993.
9. Alanazi A., Nojiri C., Noguchi T.,, et al. Improved blood compatibility of DLC coated polymeric material. ASAIO J 46: 440-443, 2000.
10. Okpalugo TI, Ogwu AA, Maguire PD,, et al. Platelet adhesion on silicon modified hydrogenated amorphous carbon films. Biomaterials 25: 239-245, 2004.
11. De Scheerden I., Szilard M., Yanming H.,, et al. Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model. J Invasive Cardiol 12: 389-394, 2000.
12. Kumari TV, Anil Kumar PR, Muraleedharan CV,, et al. In vitro cytocompatibility studies of diamond-like carbon coatings on titanium. Biomed Mater Eng 12: 329-338, 2002.
13. Moses J., Leon M., Popma J.,, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349: 1315-1323, 2003.
14. Stone G., Ellis S., Cox D.,, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350: 221-231, 2004.
15. Holmes D., Vliestra R., Smith H.,, et al. Restenosis after percutaneous transluminal coronary angioplasty: A report from the PTCA registry of the NHLBI. Am J Cardiol 57: 776-781 C, 1984.
16. Gruentzing AR, King SB III, Schumpf M.,, et al. Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience. N Engl J Med 316: 1127-1132, 1987.
17. Giedd KN, Bergmann SR: Myocardial perfusion imaging following percutaneous coronary intervention: The importance of restenosis, disease progression, and directed reintervention. J Am Coll Cardiol 43: 328-336, 2004.
18. Hernandez RA, Macaya C., Iniguez A.,, et al. Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty. J Am Coll Cardiol 19: 1402-1409, 1992.
19. Popma JJ, van den Berg EK, Dehmer GJ: Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 62: 1298-1299, 1988.
20. Teles RC, Reis-Santos K., Gil V.,, et al. A negative myocardial perfusion scintigram after coronary angioplasty confers benign long-term prognosis. Rev Port Cardiol 21: 1405-1410, 2002.
21. Dori G., Denekamp Y., Fishman S.,, et al. Exercise stress testing, myocardial perfusion imaging and stress echocardiography for detecting restenosis after successful percutaneous transluminal coronary angioplasty: A review of performance. J Intern Med 253: 253-262, 2003.
22. Vetrovec G., Disciascio G., Hugo R.,, et al. Comparative clinical and angiographic findings in patients with symptomatic and asymptomatic restenosis following angioplasty (abstract). J Am Coll Cardiol 15: 59A, 1990.
23. Bengtson JR, Mark DB, Honan MB,, et al. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. Am J Cardiol 65: 28-34, 1990.
24. Takeda Y., Kobayashi T., Awata N.,, et al. Serial six year quantitative angiographic follow-up in asymptomatic patients following successful coronary angioplasty. Heart 90: 1179-1182, 2004.
25. Lee JH, Lee CW, Park SW,, et al. Long-term follow-up after deferring angioplasty in asymptomatic patients with moderate noncritical in-stent restenosis. Clinical Cardiol 24: 551-555, 2001.
26. Carter AJ, Laird JR, Farb A.,, et al. Morphologic characteristics of lesion formation and time course of smooth muscle proliferation in a porcine restenosis model. J Am Coll Cardiol 24: 1398-1405, 1994.
27. Komowski R., Hong MK, To FO,, et al. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31: 224-230, 1998.
28. Kuntz RE, Gibson CM, Nobuyoshi M.,, et al. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional arthrectomy. J Am Coll Cardiol 21: 15-25, 1993.
29. Gutensohn K., Fetmer T., Padmanaban K.,, et al. Diamond-like carbon-coated stents, reduces platelet activation and the release of metal atoms (abstract). Infusionther Tranfusionmed 24: 299, 1997.
30. Rogers C., Edelman ER: Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 91: 2295-3001, 1995.
31. Schwartz RS, Huber KC, Murphy JG,, et al. Restenosis and proportional neointimal response to coronary arterial injury: Results in a porcine model. J Am Coll Cardiol 19: 267-274, 1992.
32. Edelman ER, Rogers C.: Hoop dreams, stents without restenosis (editorial). Circulation 94: 1199-1202, 1996.
33. Koster R., Vielhuf D., Kiehn M.,, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 356: 1895-1897, 2000.
34. Bauerschmidt P., Shaldach M.: The electrochemical aspects of the thrombogenicity of a material. J Bioengin 1: 261-278, 1977.
35. De Scheerder I., Wang K., Shier J.,, et al. Metallic surface treatment using electrochemical polishing decreases thrombogenicity and neointimal hyperplasia after coronary stent implantation in a porcine model. J Am Coll Cardiol 31: 277A, 1998.
36. Gutensohn K., Beythien C., Ban J.,, et al. In vivo analyses of diamond-like carbon-coated stents. Reduction of metal ion release, platelet activation and thrombogenicity. Thromb Res 15 ; 99: 577-585, 2000.
37. Beythien C., Gutensohn K., Kuhl P.,, et al. Influence of "diamond like" and gold coating on platelet activation: A flow cytometric analysis in a pulsed floating model (abstract). J Am Coll Cardiol 31 (suppl): 413A, 1998.
38. Beythien C., Gutensohn K., Fenner T.,, et al. Diamond-like carbon coating of coronary stents: Influence of platelet activation, smooth muscle cells and release of metal atoms (abstract). Eur J Cardiol 19 (suppl): 497, 1998.